Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10- Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-33092 LEMAITRE VASCULAR, INC. (Exact name of registrant as specified in its charter) Delaware 04-282545 ...

LeMaitre Vascular, Inc. Investor Presentation 1 Disclaimers Unaudited Quarterly Results This document contains quarterly financial results. Quarterly financial results are unaudited. Forward-Looking Statements This document contains certain forward-looking statements, within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Actual results and events may differ significantly from results and events described in forward-looking statements. Factors ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2021 Earnings Conference Call October 28, 2021 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Executive Officer Dave Roberts - President Conference Call Participants Zachary Weiner - Jefferies Rick Wise - Stifel Javier Fonseca - Spartan Capital Brooks O’Neil - Lake Street Capital Mike Petusky - Barrington Research Scott Henry - ROTH Capital Anthony Petrone - Jefferies Operator Welcome to the LeMaitre Vas ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10- Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number 001-33092 LEMAITRE VASCULAR, INC. (Exact name of registrant as specified in its charter) Delaware 04-2825458 (State o ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2021 Results Conference Call July 29, 2021 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Executive Officer Dave Roberts - President Conference Call Participants Rick Wise - Stifel Matthew Mishan - KeyBanc Capital Markets Michael Petusky - Barrington Research Operator Welcome to the LeMaitre Vascular Q2 2021 Financial Results Conference Call. As a reminder, today’s call is being recorded. At this time, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10- Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Delaware 04-2825458 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 63 Second Avenue, Burlington, Massachusetts 01803 (Address of principal executive offices) (Zip Code) (781) 221-2266 (Registrant's telephone num ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2021 Earnings Conference Call April 29, 2021 5:00 PM ET Company Participants J.J. Pellegrino – Chief Financial Officer George LeMaitre – Chairman and Chief Executive Officer Dave Roberts – President Conference Call Participants Rick Wise – Stifel Brett Fishbin – KeyBanc Frank Takkinen – Lake Street Capital Mike Petusky – Barrington Research Operator Welcome to the LeMaitre Vascular Q1 2021 Financial Results Conference Call. [Operator Instructions] At this time, I wou ...

1 LeMaitre Vascular, Inc. Investor Presentation Disclaimers Forward-Looking Statements This presentation contains certain forward-looking statements, within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Actual results and events may differ significantly from results and events discussed in forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in "Risk Factors" i ...

SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE For the transition period from to . Commission File Number 001-33092 LEMAITRE VASCULAR, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2020 Earnings Conference Call February 25, 2021 5:00 PM ET Company Participants JJ Pellegrino – Chief Financial Officer George LeMaitre – Chairman and Chief Executive Officer Dave Roberts – President Conference Call Participants Rick Wise – Stifel Brett Fishbin – KeyBanc Mike Petusky – Barrington Research James Sidoti – Sidoti & Company Operator Welcome to the LeMaitre Vascular Q4 2020 Financial Results Conference Call. As a reminder, today’s call is being recorded. ...